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1258 ABSTRACTSholding newly synthesized proteins (e.g. cytokines) that are
released constitutively or after specific stimuli.
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1999; 340: 95–101.Fig. 1. In situ detection of apoptotic eosinophils in nasal
polyp tissues. (a) Fragmented DNA in apoptotic cells was
detected by the TUNEL technique. Eosinophils were
identified by peroxidase staining. (b) Apoptotic cells were
detected by Annexin V binding. Sections wereRegulation of apoptosis in diseases
associated with eosinophilia*
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Swiss Institute of Allergy and Asthma Research (SIAF),
University of Zurich, CH-7270 Davos, Switzerlandcounterstained with haematoxylin. Original
magnification: 6 400. The figure demonstrates the
presence of apoptotic eosinophils in vivo (arrows).Apoptosis is the most common form of physiological cell
death, which is necessary to maintain correct cell numbers.
This is also true for inflammatory cells such as eosinophils
that are constantly generated in the bone marrow and die
via apoptosis (Fig. 1). Apoptosis is characterized by
morphological changes in the dying cell. The most readily
observed morphological features involve the nucleus, where
the chromatin becomes extremely condensed before a
complete collapse of the nucleus can be observed [for
eosinophils, these changes are reviewed in (1)]. Moreover, a
specific form of DNA fragmentation is another important
hallmark of apoptotic cells. There are many different
techniques to analyse DNA fragmentation. To detect
apoptosis in tissues, the terminal deoxynucleotidyl Trans-
ferase (TdT) Uridine triphosphate (UTP) Nick End
Labelling (TUNEL) method is frequently used. Another
possibility is to measure the redistribution of phosphati-
dylserine (PS) in apoptotic cells by Annexin V binding
(Fig. 1).*Work in the author’s laboratory is supported by the Swiss
National Science Foundation (grant No. 32-49210.96), the Saurer
Foundation, Zurich, the OPO Foundation, Zurich, the Foundation
for Scientific Research, Zurich, and the EMDO Foundation,
Zurich.There is increasing evidence for a pivotal role of T cells in
various diseases associated with eosinophilia such as
allergic and asthmatic diseases (2) as well as in a subgroup
of idiopathic eosinophilia (3,4). In these diseases, T cells
produce large amounts of interleukin-5, which limits
eosinophil apoptosis (5). This mechanism serves to selec-
tively amplify eosinophil accumulation (6). Overproduction
of survival factors and delayed apoptosis is not unique for
eosinophilic diseases since it can also be observed in
neutrophilic inflammation (7).
Eosinophils do not only undergo apoptosis in the
absence of survival factors. They also express at least one
functional death receptor, the Fas receptor (CD95, APO-1)
(8,9). Nitric oxide, in contrast to eosinophil haematopoie-
tins, prevents Fas receptor-mediated apoptosis in eosino-
phils (10). Thus, nitric oxide, a secretory product released in
increased amounts within chronic inflammatory responses,
might be important in determining whether an eosinophil
survives or undergoes apoptosis of eosinophils upon Fas
ABSTRACTS 1259receptor activation. We found high levels of nitric oxide
associated with Fas receptor resistance in nasal polyp
tissues. Therefore, inhibition of apoptosis of eosinophils
can be achieved by increased expression of survival factors
and disruption of death signals. Future studies will show
whether additional mechanisms exist.
The intracellular regulation of apoptosis includes mem-
bers of the Bcl-2 family. Normal eosinophils express
significant levels of Bcl-xL and Bax, but no or little Bcl-
xS and Bcl-2 (11). In allergic diseases, IL-5 upregulates Bcl-
xL, but does not alter Bax, Bcl-xS or Bcl-2 levels in
eosinophils. In contrast, Bcl-2 is expressed in eosinophils
derived from a subgroup of patients with the hypereosino-
philic syndrome (12). Overexpression of Bcl-2 in eosino-
phils delays eosinophil apoptosis in a cytokine-independent
manner.
In conclusion, delayed eosinophil apoptosis is an
important pathogenic event, which contributes to
eosinophil accumulation in diseases associated with eosi-
nophilia. Several mechanisms are described that may
participate in the inhibition of the death process. The
identification of molecules involved in the anti-apoptosis
pathways in eosinophils offers hope for the development of
new drugs that reduce inflammation in eosinophilic
disorders.
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Eosinophilic granulocytes play a key role in the host’s
defence against invading organisms; for example, they play
a particularly prominent role in the fight against parasitic
infection. They are also involved in orchestrating the
pathogenesis and propagation of certain allergic and
inflammatory diseases such as allergic rhinitis and asthma
(1). It has become abundantly clear that the development of
chronic inflammatory diseases depend not only upon the
recruitment and activation of inflammatory cells but also
upon their subsequent removal from the inflammatory
milieu (2). Apoptosis or programmed cell death is now
regarded as a fundamental process regulating inflammatory
cell survival and is critically involved in ensuring the
successful resolution of an inflammatory response (2). This
process therefore provides an ecient non-inflammatory
mechanism for removal of potentially highly histotoxic cells
from the inflamed site after the useful function of these cells
has been served. Therefore, together with preventing
excessive granulocyte invasion and activation, a parallel
strategy of selectively inducing apoptosis and augmenting
phagocytic removal of these cells should prove beneficial
for the development of novel therapeutic targets (2,3).
Eosinophils and neutrophils have a similar ontogeny, in
that they are derived from a common myeloid precursor,
and when activated these cells can exhibit similar functional
